IB 
Union Calendar No. 143 
114TH CONGRESS 
1ST SESSION H. R. 2256 
[Report No. 114–191] 
To amend title 38, United States Code, to direct the Secretary of Veterans 
Affairs to submit an annual report on the Veterans Health Administra-
tion and the furnishing of hospital care, medical services, and nursing 
home care by the Department of Veterans Affairs. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 12, 2015 
Mr. BENISHEK introduced the following bill; which was referred to the 
Committee on Veterans’ Affairs 
JULY 7, 2015 
Reported with amendments, committed to the Committee of the Whole House 
on the State of the Union, and ordered to be printed 
[Strike out all after the enacting clause and insert the part printed in italic] 
[For text of introduced bill, see copy of bill as introduced on May 12, 2015] 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
A BILL 
To amend title 38, United States Code, to direct the Sec-
retary of Veterans Affairs to submit an annual report 
on the Veterans Health Administration and the fur-
nishing of hospital care, medical services, and nursing 
home care by the Department of Veterans Affairs. 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6652
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited a the ‘‘Veterans Information 
Modernization Act’’. 
SEC. 2. ANNUAL REPORT ON VETERANS HEALTH ADMINIS-
TRATION AND FURNISHING OF HOSPITAL 
CARE, MEDICAL SERVICES, AND NURSING 
HOME CARE. 
(a) IN GENERAL.—Subchapter II of chapter 73 of title 
38, United States Code, is amended by adding at the end 
the following new section: 
‘‘§ 7330B. Annual report on Veterans Health Adminis-
tration and furnishing of hospital care, 
medical services, and nursing home care 
‘‘(a) REPORT REQUIRED.—Not later than March 1 of 
each year, the Secretary shall submit to the Committees on 
Veterans’ Affairs of the Senate and House of Representa-
tives a report on the furnishing of hospital care, medical 
services, and nursing home care under the laws adminis-
tered by the Secretary and on the administration of the pro-
vision of such care and services by the Veterans Health Ad-
ministration during the calendar year preceding the cal-
endar year during which the report is submitted. 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
‘‘(b) CONTENTS OF REPORT.—Each report required by 
subsection (a) shall include each of the following for the year 
covered by the report: 
‘‘(1) An evaluation of the effectiveness of the Vet-
erans Health Administration program in increasing 
the access of veterans eligible for hospital care, med-
ical services, and nursing home care furnished by the 
Secretary to such care. 
‘‘(2) An evaluation of the effectiveness of the Vet-
erans Health Administration in improving the qual-
ity of health care provided to such veterans, without 
increasing the costs incurred by the Government or 
such veterans, which includes the relevant informa-
tion for each medical center and Veterans Integrated 
Service Network of the Department set forth sepa-
rately. 
‘‘(3) An assessment of— 
‘‘(A) the workload of physicians and other 
employees of the Veterans Health Administra-
tion; 
‘‘(B) patient demographics and utilization 
rates; 
‘‘(C) physician compensation; 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
‘‘(D) the productivity of physicians and 
other employees of the Veterans Health Adminis-
tration; 
‘‘(E) the percentage of hospital care, med-
ical services, and nursing home care provided to 
such veterans in Department facilities and in 
non-Department facilities and any changes in 
such percentages compared to the year preceding 
the year covered by the report; 
‘‘(F) pharmaceutical prices; and 
‘‘(G) third party health billings owed to the 
Department, including the total amount of such 
billings and the total amounts collected, set forth 
separately for claims greater than $1000 and for 
claims equal to or less than $1000. 
‘‘(c) DEFINITIONS.—In this section, the terms ‘hospital 
care’, ‘medical services’, ‘nursing home care’, and ‘non-De-
partment facilities’ have the meanings given such terms in 
section 1701 of this title.’’. 
(b) CLERICAL AMENDMENT.—The table of sections at 
the beginning of such chapter is amended by inserting after 
the item relating to section 7330A the following new item: 
‘‘7330B. Annual report on Veterans Health Administration and furnishing of hos-
pital care, medical services, and nursing home care.’’. 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6213
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
SEC. 3. EXPANSION OF DEFINITION OF HOMELESS VET-
ERAN FOR PURPOSES OF BENEFITS UNDER 
THE 
LAWS 
ADMINISTERED 
BY 
THE 
SEC-
RETARY OF VETERANS AFFAIRS. 
Section 2002(1) of title 38, United States Code, is 
amended by inserting ‘‘or (b)’’ after ‘‘section 103(a)’’. 
SEC. 4. IDENTIFICATION AND TRACKING OF BIOLOGICAL 
IMPLANTS USED IN DEPARTMENT OF VET-
ERANS AFFAIRS MEDICAL FACILITIES. 
(a) IN GENERAL.—Subchapter II of chapter 73 of title 
38, United States Code, as amended by section 2, is further 
amended by adding at the end the following new section: 
‘‘§ 7330C. Identification and tracking of biological im-
plants 
‘‘(a) STANDARD IDENTIFICATION SYSTEM FOR BIO-
LOGICAL IMPLANTS.—(1) The Secretary shall adopt the 
unique device identification system developed for medical 
devices by the Food and Drug Administration pursuant to 
section 519(f) of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 360i(f)), or implement a comparable standard 
identification system, for use in identifying biological im-
plants intended for use in medical procedures conducted in 
medical facilities of the Department. 
‘‘(2) In adopting or implementing a standard identi-
fication system for biological implants under paragraph 
(1), the Secretary shall permit a vendor to use any of the 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
accredited entities identified by the Food and Drug Admin-
istration as an issuing agency pursuant to section 830.100 
of title 21, Code of Federal Regulations, or any successor 
regulation. 
‘‘(b) BIOLOGICAL IMPLANT TRACKING SYSTEM.—(1) 
The Secretary shall implement a system for tracking the 
biological implants referred to in subsection (a) from 
human donor or animal source to implantation. 
‘‘(2) The tracking system implemented under para-
graph (1) shall be compatible with the identification system 
adopted or implemented under subsection (a). 
‘‘(3) The Secretary shall implement inventory controls 
compatible with the tracking system implemented under 
paragraph (1) so that all patients who have received, in 
a medical facility of the Department, a biological implant 
subject to a recall can be notified of the recall, if based on 
the evaluation of appropriate medical personnel of the De-
partment of the risks and benefits, the Secretary determines 
such notification is appropriate. 
‘‘(c) CONSISTENCY WITH FOOD AND DRUG ADMINIS-
TRATION REGULATIONS.—To the extent that a conflict 
arises between this section and a provision of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) or 
sections 351 or 361 of the Public Health Service Act (42 
U.S.C. 262) (including any regulations issued under such 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
Acts), the provision the Federal Food, Drug, and Cosmetic 
Act or Public Health Service Act (including any regulations 
issued under such Acts) shall apply. 
‘‘(d) DEFINITION OF BIOLOGICAL IMPLANT.—In this 
section, the term ‘biological implant’ means any animal or 
human cell, tissue, or cellular or tissue-based product— 
‘‘(1) under the meaning given the term human 
cells, tissues, or cellular or tissue-based products in 
section 1271.3 of title 21, Code of Federal Regula-
tions, or any successor regulation; or 
‘‘(2) that is regulated as a device under section 
201(h) of the Federal Food, Drug, and Cosmetic 
Act.’’. 
(b) CLERICAL AMENDMENT.—The table of sections at 
the beginning of such chapter, as amended by section 2, is 
further amended by inserting after the item relating to sec-
tion 7330B, as added by section 2, the following new item: 
‘‘7330C. Identification and tracking of biological implants.’’. 
(c) IMPLEMENTATION DEADLINES.— 
(1) STANDARD IDENTIFICATION SYSTEM.— 
(A) IN GENERAL.—With respect to biologi-
cal implants described in paragraph (1) of sub-
section (d) of section 7330C of title 38, United 
States Code, as added by subsection (a), the Sec-
retary of Veterans Affairs shall adopt or imple-
ment a standard identification system for bio-
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
logical implants, as required by subsection (a) of 
such section, by not later than the date that is 
180 days after the date of the enactment of this 
Act. 
(B) IMPLANTS REGULATED AS DEVICES.— 
With respect to biological implants described in 
paragraph (2) of subsection (d) of such section, 
the Secretary of Veterans Affairs shall adopt or 
implement such standard identification system 
in compliance with the compliance dates estab-
lished by the Food and Drug Administration 
pursuant to section 519(f) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 360i(f)). 
(2) TRACKING SYSTEM.—The Secretary of Vet-
erans Affairs shall implement the biological implant 
tracking system required by section 7330C(b), as 
added by subsection (a), by not later than the date 
that is 180 days after the date of the enactment of 
this Act. 
(d) REPORTING REQUIREMENT.— 
(1) IN
GENERAL.—If the biological implant 
tracking system required by section 7330C(b) of title 
38, United States Code, as added by subsection (a), 
is not operational by the date that is 180 days after 
the date of the enactment of this Act, the Secretary of 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
Veterans Affairs shall submit to the Committees on 
Veterans’ Affairs of the Senate and House of Rep-
resentatives a written explanation for why the system 
is not operational for each month until such time as 
the system is operational. 
(2) ELEMENTS.—Each explanation submitted 
under paragraph (1) shall include a description of the 
following: 
(A) Each impediment to the implementa-
tion of the system described in such paragraph. 
(B) Steps being taken to remediate each 
such impediment. 
(C) Target dates for a solution to each such 
impediment. 
SEC. 5. PROCUREMENT OF BIOLOGICAL IMPLANTS USED IN 
DEPARTMENT OF VETERANS AFFAIRS MED-
ICAL FACILITIES. 
(a) PROCUREMENT.— 
(1) IN GENERAL.—Subchapter II of chapter 81 of 
such title is amended by adding at the end the fol-
lowing new section: 
‘‘§ 8129. Procurement of biological implants 
‘‘(a) IN GENERAL.—(1) The Secretary may procure bi-
ological implants of human origin only from vendors that 
meet the following conditions: 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
Food and Drug Administration, or by a statutory 
order of the Food and Drug Administration. 
‘‘(E) The vendor agrees to notify the Secretary of 
any adverse event or reaction report it provides to the 
Food and Drug Administration, as required by sec-
tion 1271.350 of title 21, Code of Federal Regulations, 
or any successor regulation, or any successor regula-
tion, or of any warning letter from the Food and 
Drug Administration issued to the vendor or a tissue 
processor or tissue distribution intermediary it uses 
by not later than 60 days after the vendor receives 
such report or warning letter. 
‘‘(F) The vendor agrees to retain all records asso-
ciated with the procurement of a biological implant 
by the Department for at least 10 years after the date 
of the procurement of the biological implant. 
‘‘(G) The vendor provides assurances that the bi-
ological implants provided by the vendor are acquired 
only from tissue processors that maintain active ac-
creditation with the American Association of Tissue 
Banks or a similar national accreditation specific to 
biological implants. 
‘‘(2) The Secretary may procure biological implants 
of non-human origin only from vendors that meet the fol-
lowing conditions: 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
‘‘(A) The vendor uses the standard identification 
system adopted or implemented by the Secretary 
under section 7330C(a) of this title. 
‘‘(B) The vendor is a registered establishment as 
required by the Food and Drug Administration under 
sections 807.20 and 807.40 of title 21, Code of Federal 
Regulations, or any successor regulation, (or is not 
required to register pursuant to section 807.65(a) of 
such title) and in the case of a vendor that is not the 
original product manufacturer of such implants the 
vendor provides assurances that the original product 
manufacturer is registered as required by the Food 
and Drug Administration. 
‘‘(C) The vendor agrees to cooperate with all bio-
logical implant recalls conducted on the vendor’s own 
initiative, on the initiative of the original product 
manufacturer used by the vendor, by the request of the 
Food and Drug Administration, or by a statutory 
order of the Food and Drug Administration. 
‘‘(D) The vendor agrees to notify the Secretary of 
any adverse event report it provides to the Food and 
Drug Administration as required in part 803 of title 
21, Code of Federal Regulations, or any warning let-
ter from the Food and Drug Administration issued to 
the vendor or the original product manufacturer it 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
uses by not later than 60 days after the vendor re-
ceives such report or warning letter. 
‘‘(E) The vendor agrees to retain all records as-
sociated with the procurement of a biological implant 
by the Department for at least 10 years after the date 
of the procurement of the biological implant. 
‘‘(3)(A) The Secretary shall procure biological im-
plants under the Federal Supply Schedules of the General 
Services Administration unless such implants are not avail-
able under such Schedules. 
‘‘(B) With respect to biological implants listed on the 
Federal Supply Schedules, the Secretary shall accommodate 
reasonable vendor requests to undertake outreach efforts to 
educate medical professionals of the Department about the 
use and efficacy of such biological implants. 
‘‘(C) In the case of biological implants that are un-
available for procurement under the Federal Supply Sched-
ules, the Secretary shall procure such implants using com-
petitive procedures in accordance with applicable law and 
the Federal Acquisition Regulation. 
‘‘(4) Section 8123 of this title shall not apply to the 
procurement of biological implants. 
‘‘(b) PENALTIES.—In addition to any applicable pen-
alty under any other provision of law, any procurement 
employee of the Department who is found responsible for 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
a biological implant procurement transaction with intent 
to avoid or with reckless disregard of the requirements of 
this section shall be ineligible to hold a certificate of ap-
pointment as a contracting officer or to serve as the rep-
resentative of an ordering officer, contracting officer, or 
purchase card holder. 
‘‘(c) DEFINITIONS.—In this section: 
‘‘(1) The term ‘biological implant’ shall have the 
meaning given such term in section 7330C(d) of this 
title. 
‘‘(2) The term ‘distinct identity code’ means a 
code that— 
‘‘(A) relates a biological implant to the 
human donor of the implant and to all records 
pertaining to the implant; 
‘‘(B) includes information designed to fa-
cilitate effective tracking, using such code, from 
the donor to the recipient and from the recipient 
to the donor; and 
‘‘(C) satisfies the requirements of section 
1271.290 of title 21, Code of Federal Regula-
tions, or any successor regulation. 
‘‘(3) The term ‘tissue distribution intermediary’ 
means an agency that acquires and stores human tis-
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
sue for further distribution and performs no other tis-
sue banking functions. 
‘‘(4) The term ‘tissue processor’ means an entity 
processing human tissue for use in biological im-
plants including activities performed on tissue other 
than donor screening, donor testing, tissue recovery 
and collection functions, storage, or distribution.’’. 
(2) CLERICAL AMENDMENT.—The table of sec-
tions at the beginning of such chapter is amended by 
adding at the end of the items relating to such sub-
chapter the following new item: 
‘‘8129. Procurement of biological implants.’’. 
(b) EFFECTIVE DATE.—Section 8129 of title 38, 
United States Code, as added by subsection (a), shall take 
effect on the date that is 180 days after the date on which 
the tracking system required under subsection (b) of section 
7330C of such title, as added by section 4(a) is imple-
mented. 
(c) SPECIAL
RULE
FOR
CRYOPRESERVED
PROD-
UCTS.—During the three-year period beginning on the effec-
tive date of section 8129 of title 38, United States Code, 
as added by subsection (a), biological implants produced 
and labeled before that date may be procured by the Depart-
ment of Veterans Affairs without relabeling under the 
standard identification system adopted or implemented 
under section 7330C of such title, as added by section 4(a). 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
SEC. 6. EXTENSION OF ROUNDING DOWN OF PERCENTAGE 
INCREASES OF RATES OF CERTAIN EDU-
CATIONAL ASSISTANCE. 
(a) MONTGOMERY GI BILL.—Section 3015(h)(2) of 
title 38, United States Code, is amended— 
(1) by striking ‘‘fiscal year 2014’’ and inserting 
‘‘fiscal year 2020’’; and 
(2) by striking ‘‘fiscal year 2013’’ and inserting 
‘‘fiscal year 2019’’. 
(b) SURVIVORS AND DEPENDENTS EDUCATIONAL AS-
SISTANCE.—Section 3564(b) of such title is amended— 
(1) by striking ‘‘fiscal year 2014’’ and inserting 
‘‘fiscal year 2020’’; and 
(2) by striking ‘‘fiscal year 2013’’ and inserting 
‘‘fiscal year 2019’’. 
SEC. 7. VETERANS EXPEDITED RECOVERY COMMISSION. 
(a) ESTABLISHMENT.—There is established the Vet-
erans Expedited Recovery Commission (in this section re-
ferred to as the ‘‘Commission’’). 
(b) DUTIES.—The Commission shall perform the fol-
lowing duties: 
(1) Examine the efficacy of the evidence-based 
therapy model used by the Secretary of Veterans Af-
fairs for treating mental health illnesses of veterans 
and identify areas to improve wellness-based out-
comes. 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
ments for veterans for addressing mental health 
issues, including by identifying ways to reduce 
barriers to and gaps in such benefits and treat-
ments. 
(3) Examine available research on complemen-
tary alternative treatment therapies for mental health 
issues and identify what benefits could be made with 
the inclusion of such treatments for veterans, includ-
ing with respect to— 
(A) music therapy; 
(B) equine therapy; 
(C) training and caring for service dogs; 
(D) yoga therapy; 
(E) acupuncture therapy; 
(F) meditation therapy; 
(G) outdoor sports therapy; 
(H) hyperbaric oxygen therapy; 
(I) accelerated resolution therapy; and 
(J) other therapies the Commission deter-
mines appropriate. 
(4) Study the potential increase of claims relat-
ing to mental health issues submitted to the Secretary 
by veterans who served in Operation Enduring Free-
dom, Operation Iraqi Freedom, or Operation New 
Dawn, including an assessment of the resources avail-
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
able within the Department to ensure that quality 
health care demands relating to such claims can be 
delivered in a timely manner. 
(c) MEMBERSHIP.— 
(1) NUMBER AND APPOINTMENT.— 
(A) IN GENERAL.—The Commission shall be 
composed of 10 members, appointed as follows: 
(i) Two members appointed by the 
Speaker of the House of Representatives, at 
least one of whom shall be a veteran. 
(ii) Two members appointed by the 
Minority Leader of the House of Represent-
atives, at least one of whom shall be a vet-
eran. 
(iii) Two members appointed by the 
Majority Leader of the Senate, at least one 
of whom shall be a veteran. 
(iv) Two members appointed by the 
Minority Leader of the Senate, at least one 
of whom shall be a veteran. 
(v) Two members appointed by the 
President, at least one of whom shall be a 
veteran. 
(B) 
QUALIFICATIONS.—Members 
of 
the 
Commission shall be— 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
(i) individuals who are of recognized 
standing and distinction within the medical 
community with a background in treating 
mental health; 
(ii) individuals with experience work-
ing with the military and veteran popu-
lation; and 
(iii) individuals who do not have a fi-
nancial interest in any of the complemen-
tary alternative treatments reviewed by the 
Commission. 
(2) CHAIRMAN.—The President shall designate a 
member of the Commission to be the chairman. 
(3) PERIOD OF APPOINTMENT.—Members of the 
Commission shall be appointed for the life of the 
Commission. 
(4) VACANCY.—A vacancy in the Commission 
shall be filled in the manner in which the original 
appointment was made. 
(5) APPOINTMENT DEADLINE.—The appointment 
of members of the Commission in this section shall be 
made not later than 90 days after the date of the en-
actment of this Act. 
(d) POWERS OF COMMISSION.— 
(1) MEETING.— 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
(A) INITIAL
MEETING.—The Commission 
shall hold its first meeting not later than 30 
days after a majority of members are appointed 
to the Commission. 
(B) MEETING.—The Commission shall regu-
larly meet at the call of the Chairman. Such 
meetings may be carried out through the use of 
telephonic or other appropriate telecommuni-
cation technology if the Commission determines 
that such technology will allow the members to 
communicate simultaneously. 
(2) HEARING.—The Commission may hold such 
hearings, sit and act at such times and places, take 
such testimony, and receive evidence as the Commis-
sion considers advisable to carry out the responsibil-
ities of the Commission. 
(3) INFORMATION FROM FEDERAL AGENCIES.— 
The Commission may secure directly from any de-
partment or agency of the Federal Government such 
information as the Commission considers necessary to 
carry out the duties of the Commission. 
(4) INFORMATION FROM NONGOVERNMENTAL OR-
GANIZATIONS.—In carrying out subsection (b), the 
Commission may seek guidance through consultation 
with foundations, veterans service organizations, non-
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
profit groups, faith-based organizations, private and 
public institutions of higher education, and other or-
ganizations as the Commission determines appro-
priate. 
(5) COMMISSION
RECORDS.—The Commission 
shall keep an accurate and complete record of the ac-
tions and meetings of the Commission. Such record 
shall be made available for public inspection and the 
Comptroller General of the United States may audit 
and examine such record. 
(6) PERSONNEL MATTERS.—Upon request of the 
chairman of the Commission, the head of any depart-
ment or agency of the Federal Government may de-
tail, on a reimbursable basis, any personnel of that 
department or agency to assist the Commission in 
carrying out the duties of the Commission. 
(7) COMPENSATION OF MEMBERS; TRAVEL EX-
PENSES.—Each member shall serve without pay, ex-
cept that each member shall receive travel expenses to 
perform the duties of the Commission under sub-
section (b), including per diem in lieu of subsistence, 
at rates authorized under subchapter I of chapter 57 
of title 5, United States Code. 
(8) STAFF.—The Chairman, in accordance with 
rules agreed upon by the Commission, may appoint 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
and fix the compensation of a staff director and such 
other personnel as may be necessary to enable the 
Commission to carry out its functions, without regard 
to the provisions of title 5, United States Code, gov-
erning appointments in the competitive service, with-
out regard to the provision of chapter 51 and sub-
chapter III of chapter 53 of such title relating to clas-
sification and General Schedule pay rates, except that 
no rate of pay fixed under this subsection may exceed 
the equivalent of that payable for a position at a level 
IV of the Executive Schedule under section 5316 of 
title 5, United States Code. 
(9) PERSONNEL AS FEDERAL EMPLOYEES.— 
(A) IN
GENERAL.—The executive director 
and any personnel of the Commission are em-
ployees under section 2105 of title 5, United 
States Code, for purpose of chapters 63, 81, 83, 
84, 85, 87, 89, and 90 of such title. 
(B) MEMBERS OF THE COMMISSION.—Sub-
paragraph (A) shall not be construed to apply to 
members of the Commission. 
(10) CONTRACTING.—The Commission may, to 
such extent and in such amounts as are provided in 
appropriations Acts, enter into contracts to enable the 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
Commission to discharge the duties of the Commission 
under this section. 
(11) EXPERT AND CONSULTANT SERVICE.—The 
Commission may procure the services of experts and 
consultants in accordance with section 3109 of title 5, 
United States Code, at rates not to exceed the daily 
rate paid to a person occupying a position at level IV 
of the Executive Schedule under section 5315 of title 
5, United States Code. 
(12) POSTAL SERVICE.—The Commission may 
use the United States mails in the same manner and 
under the same conditions as departments and agen-
cies of the United States. 
(13) PHYSICAL FACILITIES AND EQUIPMENT.— 
Upon the request of the Commission, the Adminis-
trator of General Services shall provide to the Com-
mission, on a reimbursable basis, the administrative 
support services necessary for the Commission to 
carry out its responsibilities under this section. These 
administrative services may include human resource 
management, budget, leasing, accounting, and payroll 
services. 
(e) REPORT.— 
(1) INTERIM REPORTS.— 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
(A) IN GENERAL.—Not later than 60 days 
after the date on which the Commission first 
meets, and each 30-day period thereafter ending 
on the date on which the Commission submits 
the final report under paragraph (2), the Com-
mission shall submit to the Committees on Vet-
erans’ Affairs of the House of Representatives 
and the Senate and the President a report detail-
ing the level of cooperation the Secretary of Vet-
erans Affairs (and the heads of other depart-
ments or agencies of the Federal Government) 
has provided to the Commission. 
(B) OTHER REPORTS.—In carrying out the 
duties pursuant to subsection (b), at times that 
the Commission determines appropriate, the 
Commission shall submit to the Committees on 
Veterans’ Affairs of the House of Representatives 
and the Senate and any other appropriate enti-
ties an interim report with respect to the find-
ings identified by the Commission. 
(2) FINAL REPORT.—Not later than 18 months 
after the first meeting of the Commission, the Com-
mission shall submit to the Committees on Veterans’ 
Affairs of the House of Representatives and the Sen-
ate, the President, and the Secretary of Veterans Af-
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
fairs a final report on the findings of the Commis-
sion. Such report shall include the following: 
(A) Recommendations to implement in a 
feasible, timely, and cost-effective manner the so-
lutions and remedies identified within the find-
ings of the Commission pursuant to subsection 
(b). 
(B) An analysis of the evidence-based ther-
apy model used by the Secretary of Veterans Af-
fairs for treating veterans with mental health 
care issues, and an examination of the preva-
lence and efficacy of prescription drugs as a 
means for treatment. 
(C) The findings of the patient-centered sur-
vey conducted within each of the Veterans Inte-
grated Service Networks pursuant to subsection 
(b)(2). 
(D) An examination of complementary al-
ternative treatments described in subsection 
(b)(3) and the potential benefits of incorporating 
such treatments in the therapy model used by the 
Secretary for treating veterans with mental 
health issues. 
(3) PLAN.—Not later than 90 days after the date 
on which the Commission submits the final report 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
under subsection (b), the Secretary of Veterans Affairs 
shall submit to the Committees on Veterans’ Affairs of 
the House of Representatives and the Senate a report 
on the following: 
(A) An action plan for implementing the 
recommendations established by the Commission 
on such solutions and remedies for improving 
wellness-based outcomes for veterans with mental 
health care issues. 
(B) A feasible timeframe on when com-
plementary alternative treatments described in 
subsection (b)(3) can be implemented Depart-
ment-wide. 
(C) With respect to each recommendation 
established by the Commission, including regard-
ing any complementary alternative treatment, 
that the Secretary determines is not appropriate 
or feasible to implement, a justification for each 
such determination and an alternative solution 
to improve the efficacy of the therapy model used 
by the Secretary for treating veterans with men-
tal health issues. 
(f) TERMINATION OF COMMISSION.—The Commission 
shall terminate 30 days after the Commission submits the 
final report under subsection (e)(2). 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6203
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS
Amend the title so as to read: ‘‘A bill to amend title 
38, United States Code, to direct the Secretary of Vet-
erans Affairs to submit an annual report on the Veterans 
Health Administration, to provide for the identification 
and tracking of biological implants used in Department 
of Veterans Affairs facilities, and for other purposes.’’. 
VerDate Sep 11 2014 
23:34 Jul 07, 2015
Jkt 049200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6201
E:\BILLS\H2256.RH
H2256
SSpencer on DSK4SPTVN1PROD with BILLS